CDKN2A and acute lymphoblastic leukemia: Early T cell precursor-ALL (ETP-ALL) and T cell-ALL (T-ALL) models are predominantly characterized by CDKN2A/B focal deletions (72%–76%; Figure S4B) and/or a NOTCH1 mutation (68%).